Find Funding Opportunities

Find Funding Opportunities

Subscribe to Find Funding OpportunitiesRSS
Filter By:
Returning 62 results

Notice of Special Interest: Advancing Research for Tickborne Diseases (TBDs)

Notice of Special Interest
Tuesday, November 12, 2019
Sunday, January 8, 2023
NOT-AI-20-005
May Wong

Funding Opportunity Purpose

Notice Special Interest: Advancing Research Tickborne Diseases TBDs) Notice Number: NOT-AI-20-005 Key Dates Release Date: November 12, 2019 First Available Due Date: January 05, 2020 Expiration Date: January 08, 2023 Related Announcements PA-19-055 NIH Research Project Grant Parent R01 Clinical Trial Required) PA-19-056 NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-270 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) PA-19-272 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) PAR-19-134 Research Enhancement Award Program REAP) Health Professional Schools Graduate Schools R15 Clinical Trial Allowed) Issued National Institute Allergy Infectious Diseases NIAID ) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Mental Health NIMH ) National Institute Neurological Disorders Stroke NINDS) National Center Complementary Integrative Health NCCIH ) Purpose purpose this Notice to announce the National Institute Allergy Infectious Diseases NIAID), National Institute Arthritis Musculoskeletal Skin Diseases NIAMS), National Institute Mental Health NIMH), National Institute Neurological Disorders Stroke NINDS), the National Center Complementary Integrative Health NCCIH) encourage new applications advance research activities relevant the five strategic priorities identified the recently released NIH Strategic Plan Tickborne Disease Research: Improve fundamental knowledge TBDs to understand host, vector, pathogen factors drive TBD pathogenesis transmission. Elucidate host immune mechanisms response and exploited TBD pathogens. Advance research improve diagnosis TBDs using both host- pathogen-targeted approaches, including research rapid diagnostics multiplex platform approaches detect multiple tickborne pathogens. Accelerate research improve TBD prevention by supporting science design, develop, evaluate vaccines, vector control strategies, other prevention approaches. Promote research improve treatment all forms TBDs, including studies develop effective therapies treat symptoms persist after TBD treatment, therapies non-infectious TBDs, new antimicrobials. Support tools resources advance research understanding, preventing, diagnosing, treating TBDs, including repositories, genomic resources, animal models, preclinical services aid development assessment diagnostic, vaccine, therapeutic candidates. NIAID: NIAID support research the biology tickborne pathogens, vectors, animal reservoirs, human hosts, the interactions among elements they help understand underlying causes human disease. NIAID interested applications the basic science behind tickborne infections in applications seeking develop new approaches prevent, diagnose, treat those infections. NIAID also support research non-infectious TBDs, particularly alpha-gal syndrome. focus research this syndrome to understand pathogenesis develop improved diagnostics therapeutic approaches. NIAMS : NIAMS interested supporting research studies human immunity its role the initiation propagation Lyme arthritis. of systems biology approaches identify critical cellular molecular pathways involved pathogenesis encouraged. interests include studies the joint tissue remodeling pathways the cross-talk a wide range hematopoietic other cell types Lyme arthritis. Please note, NIAMS only accepts mechanistic studies meet NIH's definition a clinical trial PA-19-055. NIMH: As lead federal agency research mental disorders, NIMH interested the following areas: Basic mechanistic neuroscience studies persistent effects Lyme disease brain signaling, circuits, proximal effects functional processes such cognition are impaired mental illnesses. Research illuminate mechanisms which tick-borne diseases lead specific psychiatric complications. Research understand neurobiological basis the impact tick-borne diseases specific domains functions relevant mental health, informed the Research Domain Criteria RDoC) approach. Research decrease burden acute chronic psychiatric complications Lyme disease other tick-borne diseases. Please note, NIMH only accepts mechanistic studies meet NIH's definition a clinical trial PA-19-055. NINDS : NINDS interested supporting research the basic biology mechanisms the neurological consequences tick-borne diseases. includes developing animal cell models will facilitate studying nervous system pathogenesis these diseases developing new approaches diagnose treat neurological complications. Please note, NINDS only accepts mechanistic studies meet NIH's definition a clinical trial PA-19-055. NCCIH: NCCIH support research the mechanisms which complementary integrative health approaches improve tick-borne disease TBD) treatment and/or post-TBD symptom care. Complementary integrative approaches include mind/brain-focused practices i.e., meditation, hypnosis), body-based approaches i.e., acupuncture, massage, spinal manipulation), meditative exercise i.e., yoga, tai chi, qi gong), natural products i.e., botanicals, dietary supplements, probiotics), isolation in combination conventional medical treatments. NCCIH not accept clinical trial measures efficacy effectiveness any intervention through NOSI. NCCIH only accepts mechanistic studies meet NIH's definition a clinical trial PA-19-055. Application Submission Information notice applies due dates or after January 5, 2020 subsequent receipt dates through January 8, 2023. Submit applications this initiative using of following funding opportunity announcements FOAs) any reissues these announcement through expiration date this notice. PA-19-055 NIH Research Project Grant Parent R01 Clinical Trial Required) PA-19-056 NIH Research Project Grant Parent R01 Clinical Trial Allowed) PA-19-270 PHS 2019-02 Omnibus Solicitation the NIH Small Business Technology Transfer Grant Applications Parent STTR R41/R42] Clinical Trial Allowed) PA-19-272 PHS 2019-02 Omnibus Solicitation the NIH, CDC, FDA Small Business Innovation Research Grant Applications Parent SBIR R43/R44] Clinical Trial Allowed) PAR-19-134 Research Enhancement Award Program REAP) Health Professional Schools Graduate Schools R15 Clinical Trial Allowed) instructions the SF424 R&R) Application Guide and funding opportunity announcement used submission must followed, the following additions: funding consideration, applicants must include ldquo;NOT-AI-20-005” without quotation marks) the Agency Routing Identifier field box 4B) the SF424 R&R form. Applications without information box 4B not considered this initiative. Applications nonresponsive terms this NOSI be be considered the NOSI initiative. Inquiries Please direct inquiries to: Samuel Perdue, Ph.D. National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3341 E-mail: sperdue@nih.gov Yisong Wang, PhD. National Center Complementary Integrative Health NCCIH) Telephone: 301-480-9483 E-mail: yisong.wang@nih.gov Su-Yau Mao, Ph.D. National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-594-5032 Email: maos2@mail.nih.gov Sarah H. Lisanby, M.D.. National Institute Mental Health NIMH) Telephone: 301-451-3029 Email: lisanbysh@mail.nih.gov Wong, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1431 Email: wongm@ninds.nih.gov

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

PAS
Thursday, July 18, 2019
Translational Research, Clinical Trials Research
Wednesday, September 7, 2022
R41/R42
PAS-19-317

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) invites applications to NIA's Small Business Technology Transfer Research (STTR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

PAS
Thursday, July 18, 2019
Translational Research, Clinical Trials Research
Wednesday, September 7, 2022
R43/R44
PAS-19-316

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) invites applications to NIA's Small Business Innovation Research (SBIR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients.

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

PAR
Wednesday, May 8, 2019
Sunday, May 8, 2022
R01
PAR-19-274

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

PAR
Wednesday, May 8, 2019
Sunday, May 8, 2022
R03
PAR-19-276
Robin Conwit

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

PAR
Wednesday, May 8, 2019
Sunday, May 8, 2022
R21
PAR-19-275

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.

Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)

PAR
Wednesday, March 13, 2019
Thursday, February 17, 2022
U01
PAR-19-220
Glen Nuckolls

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical studies that address critical needs for clinical trial readiness in rare neurological and neuromuscular diseases. These studies should result in clinically validated biomarkers and clinical outcome assessment measures appropriate for use in upcoming clinical trials. Through the support of trial readiness studies, NINDS and NCATS expect to enhance the quality and increase the likelihood of success of clinical trials in these rare diseases.

Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations

Notice of Special Interest
Wednesday, March 13, 2019
Monday, May 8, 2023
NOT-MD-19-001

Funding Opportunity Purpose

Notice Special Interest Research the Health Sexual Gender Minority SGM) Populations Notice Number: NOT-MD-19-001 Key Dates Release Date: March 13, 2019 Related Announcements None Issued National Institute Minority Health Health Disparities NIMHD) National Center Complementary Integrative Health NCCIH) National Cancer Institute NCI) National Human Genome Research Institute NHGRI) National Heart, Lung, Blood Institute NHLBI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy ShriverNational Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) Office Behavioral Social Sciences Research OBSSR) Office Disease Prevention ODP) Office Research Womens Health ORWH) Sexual & Gender Minority Research Office SGMRO) Purpose Notice calls research the health sexual gender minority populations. Sexual gender minority" an umbrella term encompasses lesbian, gay, bisexual, transgender populations well those whose sexual orientation, gender identity expressions, reproductive development varies traditional, societal, cultural, physiological norms. includes individuals disorders differences sex development DSD), sometimes known intersex. Although has an increase SGM-focused health research recent years, remains need further research the health these populations. Notice encourages research describes biological, clinical, behavioral, social processes affect health development SGM populations individuals their families, that leads the development acceptable appropriate health interventions health service delivery methods will enhance health development these populations. Types research are relevant this Notice include, are limited to: Epidemiological research examines patterns risk, morbidity mortality related diseases health conditions have been adequately studied SGM populations. Etiological mechanistic research examining biological, behavioral, social, and/or environmental factors contribute health outcomes health disparities SGM populations. Research leading interventions ameliorate health disparities SGM populations, including formative research identify develop appropriate intervention content well pilot testing interventions establish feasibility, acceptability, preliminary efficacy. Large-scale design, implementation evaluation preventive and/or treatment interventions addressing health issues SGM populations. Possible funding opportunity announcements FOAs) their re-issues which SGM-related research be submitted include are limited Parent FOAs Research R), Career Development K), Fellowship F) awards Parent Announcements Unsolicited Investigator Initiated Applications)":https://grants.nih.gov/grants/guide/parent_announcements.htm. Applicants should carefully note participating Institutes/Centers each FOA. Applications must in mission an Institute/Center listed Components Participating Organizations the FOA. Offices listed this Notice consider co-funding applications assigned an Institute/Center participates the FOA. Investigators strongly encouraged reach to relevant contacts listed below identify FOAs be most appropriate their proposed project application. Applicants should indicate Notice number NOT-MD-19-001) Field 4.b the SF 424 application form refer NOT-MD-19-001 the abstract assist identifying applications submitted this Notice. Areas programmatic interest toNIMHDinclude are limited to: Observational studies how social determinants, such minority stress, stigma discrimination, lack access culturally competent healthcare, social networks, social support, cause, sustain, ameliorate health disparities. Epidemiological studies the relationship between intersectionality SGM status other health disparity population membership health outcomes. addition SGM populations, NIH-designated health disparity populations include racial/ethnic minorities, socioeconomically disadvantaged populations, underserved rural populations. Intervention studies community healthcare settings reduce health disparities. NIMHDencourages projects use approaches encompass multiple domains e.g., biological, behavioral, socio-cultural, environmental, physical environment, health system) multiple levels e.g., individual, interpersonal, community, societal) understand address health disparities SGM populations the NIMHD Research Framework,https://www.nimhd.nih.gov/about/overview/research-framework.html, examples health determinants interest). Animal studies studies focused SGM populations outside the US not priorities NIMHD under Notice. NCCIHis interested supporting research the of complementary integrative health approaches, including natural products mind body interventions, manage stress, chronic pain, mild anxiety, depression among SGM populations. NCCIH also interested research studying mind body approaches improve adherence treatment e.g., Medication Assisted Treatment MAT) opioid misuse, Antiretroviral therapy ART) HIV) prevention e.g., Pre-exposure prophylaxis PrEP) HIV) regimens promote health outcomes. Natural products include botanicals, pre/probiotics, products marketed dietary supplements. Mind body approaches include various meditation approaches e.g., mindfulness), hypnosis guided imagery, meditative movement approaches e.g., yoga, tai chi, qi-gong), body-based approaches e.g., spinal manipulation, massage, mobilization, acupuncture), combination these approaches e.g., meditation yoga, such in mindfulness-based stress reduction MBSR), complex interventions including music art therapy. NCCIH offers range funding opportunity announcements support clinical trials natural products mind body interventions. Applicants strongly encouraged consult the NCCIH Scientific Research contact prior developing submitting application. Areas programmatic interest toNCIinclude are limited to) studies that: Identify cancer health care needs across cancer continuum, including prevention, early detection, diagnosis, treatment, survivorship, end life care among SGM populations; Increase understanding the cancer care needs, health outcomes effective interventions improve outcomes SGM individuals; Assess cancer risk inform improved decision-making, risk reduction interventions, screening options early cancer detection SGM populations; Evaluate interventions increase rates screening, follow-up, referral-to-care, improve symptom management cancer prevention control among SGM populations; Increase understanding the barriers cancer health care information treatment may lead SGM individuals/populations avoid delay seeking health care; Examine relative risk cancer cancer risk factors e.g., smoking, obesity, aging, infections such HPV HIV, tobacco use, alcohol consumption, nulliparity) underlying mechanisms risk social, behavioral, biological, clinical) SGM groups comparison their heterosexual counterparts; Investigate cancer patient outcomes, cancer treatment delivery, healthcare utilization SGMs; Improve understanding the differential risks certain types cancers including cervical, breast, ovarian, anal, other malignancies among SGMs; Examine potential cancer risks hormone therapy including off-label use) among transgender and/or intersex individuals; Investigate prevalence rates HPV infection SGM groups the development screening interventions and/or recommendations ameliorate HPV-associated disease; Examine intersection contextual factors e.g., race, geography, socioeconomic status) cancer health outcomes across SGM groups; Investigate lack access and utilization cancer health care services, quality care received, SGM populations impact health outcomes; Assess impact stigma, discrimination, victimization, substance use, other risk factors utilization cancer preventive screening/services; Investigate positive and/or protective factors e.g., family and/or social support) cancer prevention. Areas programmatic interest toNHGRIinclude are limited to: Development resources, approaches, technologies will accelerate genomic research the structure genomes, biology genomes, the biology disease; Developments will genomics advance science medicine, that incorporate genomics improve effectiveness healthcare; Research several cross-cutting areas, including ethical, legal societal implications genomics research, bioinformatics, research training career development. NHLBIprovides global leadership a research, research training, education program promote prevention treatment heart, lung, blood, sleep diseases enhance health all individuals that can live longer more fulfilling lives. NHLBI encourages research designed answer breadth scientific questions related heart, lung, blood, and/or sleep diseases, disorders, phenotypes. NHLBI seeks research applications(R01 applications only)that address questions relevant the NHLBI mission, address gaps the NHLBIs portfolio clinical epidemiology cohort studies should align the NHLBIs Strategic Vision. NHLBIs strategic priorities emphasize continuum research basic molecular biology research implementation science related heart, lung, blood, sleep disorders e.g., Sickle Cell Disease other hemoglobinopathies; cardiovascular diseases; hypertension prevention control; asthma; chronic obstructive pulmonary disease COPD); sleep apnea; other cardiopulmonary diseases conditions), self-management symptoms disease conditions, prevention these diseases disorders various populations. NHLBI also significant interests implementation science research the prevention, control, treatment heart, lung, blood diseases, sleep disorders, particularly research addresses development interventions strategies address translation proven-effective, evidence-based interventions clinical, community, and/or settings; addresses impediments uptake, scale up, sustainability evidence-based research. Please refer the NHLBI website more details the research priorities the NHLBI:https://www.nhlbi.nih.gov/about/documents/strategic-vision. NIAis interested research can improve understanding aging processes andexperiences impact health well-being middle-aged older SGM adults well studies focused early life exposures contribute SGM health disparities adulthood. NIA encourages of multi-level analysis individual, dyadic, family, community/institution, population data, consideration multidimensional measures sexual orientation identity, attraction, behavior) diverse gender categories. NIA supports cross-national studies better understand aging experience a global level the effects various policies. Natural experiments, arising policy change regional differences, provide another powerful approach examining mechanisms affecting health SGM older adults. Applicants encouraged leverage NIAs investment data infrastructure publicly available datasets. NIAsOffice Research Resources.) Areas programmatic interest toNIAinclude are limited to: Studies examining interpersonal processes, the situational contexts influence them, lead positive healthy relationships adulthood older age. NIA especially interested research can identify causal mechanisms accounting links between marital status, long-term romantic partnerships, health. Studies examining factors such social identity, intersectionality, positionality, stigma impact interpersonal interactions, well-being, health later life. Causes consequences self-disclosing sexual orientation gender identity mid-late life older age families, intimate partners, employers, health care practitioners, institutions. Studies unique caregiving needs older SGM individuals, especially, individuals Alzheimers disease related dementias their families origin chosen). Interventions promote healthy aging reduce health disparities SGM adults.NIA encourages mechanism-focused approach intervention development promoted theNIH Science Behavior Changeand theNIH Stage Model. NIA also supports pragmatic trial development Introduction pragmatic clinical trials"). Data infrastructure method development support studies older SGM adults, including development representative population cohorts older SGM adults adequate sample size study issues intersectionality, the addition cohort-sensitive SGM measures existing studies. includes development novel recruitment strategies methods approaches identifying assessing unique issues needs older SGM adults. NIAAAseeks innovative applications the areas of: Epidemiological research examines patterns risk, morbidity mortality related alcohol disorders AUDs) SGM populations, including studies 1) risk protective factors heavy including binge) drinking AUDs; 2) correlates underage drinking related problems among SGM populations; 3) factors influence transitions and of problem drinking patterns across lifespan among SGM populations; 4) consequences, drinking related problems, may attributable the combination racial/ethnic minority status addition SGM status. Etiological mechanistic researchincluding human laboratory-based researchexamining biological, behavioral, social, and/or environmental factors contribute drinking-related outcomes SGM populations. Research leading interventions ameliorate drinking related problems SGM populations, including formative research identify develop appropriate intervention content well pilot testing interventions establish feasibility, acceptability, preliminary efficacy. Design, implementation evaluation preventive and/or treatment interventions address AUDs related problems that appropriate the needs SGM populations. Such projects extend evaluations screening, assessment, brief interventions, referral alcohol treatment; other individual-level preventive approaches, such protective strategies; studies assess drinking prevention approaches enlist families peers online offline); studies focus the effects community/institutional-level alcohol policies preventing drinking related problems among SGM populations; studies look alcohol treatment efficacy among SGM populations. Areas programmatic interest toNIAIDinclude are limited to: Research all areas HIV infection, including developing testing preventive HIV vaccines, other prevention strategies, new treatments HIV infection AIDS-associated opportunistic infections Basic applied research better understand, treat, ultimately prevent infectious, immunologic, allergic diseases. Training career development e.g. T, F, K) applications rural urban institutions may underserved SGM populations. mission ofNIAMSis support research the causes, treatment, prevention arthritis musculoskeletal skin diseases; training basic clinical scientists carry this research; the dissemination information research progress these diseases. NIAMS also conducts supports basic research the normal structure function bones, joints, muscles, skin. Basic research involves wide variety scientific disciplines, including immunology, genetics, molecular biology, structural biology, biochemistry, physiology, virology, pharmacology. Clinical research areas include rheumatology, orthopaedics, dermatology, metabolic bone diseases, heritable disorders bone cartilage, inherited inflammatory muscle diseases, sports rehabilitation medicine. NIAMS also seeks studies include sufficient numbers SGM individuals enable robust sub-group analyses. Clinical trials designed answer specific questions the safety, tolerability, efficacy, effectiveness, clinical management, and/or implementation pharmacologic, behavioral, biologic, surgical, device invasive non-invasive) interventions only supported NIAMS submitted a NIAMS clinical trials-specific FOA. current list active NIAMS clinical trials FOAs available athttps://www.niams.nih.gov/grants-funding/conducting-clinical-research/grants. information regarding NIAMS supported scientific areas/programs contacts, please see:https://www.niams.nih.gov/grants-funding/supported-scientific-areas. TheNICHDsupports biological, behavioral, clinical research related conception pregnancy, normal abnormal development childhood, reproductive health, population dynamics across lifespan, rehabilitation medicine https://www.nichd.nih.gov/grantsfunding/opportunities-mechanisms/areas-research/Pages/default.aspx). Research projects considered funding NICHD must fall within scientific missions the twelve Scientific Branches the NICHD Division Extramural Research DER) the National Center Medical Rehabilitation Research NCMRR). Information those scientific missions program staff contacts be found the web pages the DER scientific branches at:http://www.nichd.nih.gov/about/org/der/branches/Pages/index.aspxand NCMRR at:http://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx. Potential applicants strongly encouraged read webpages any updates response recent scientific advances emerging public health topics. NICHD encourages applications address extramural program priorities will consider well research projects align one more those priorities making award decisions. detailed list NICHD high priority research areas be found athttps://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areasresearch/Pages/priorities.aspx Areas programmatic interest toNIDAinclude are limited to: Innovative drug abuse epidemiology, prevention, health services research among SGM populations; Translational research applies findings epidemiology, cognitive science, neuroscience, other sciences develop test novel prevention interventions among SGM populations; Treatment development research testing substance disorders, including behavioral treatments, among SGM populations; Vulnerability addiction biological etiology among SGM populations; Behavioral cognitive mechanisms consequences substance polysubstance among SGM populations. Areas programmatic interest toNIDCRinclude are limited to: Research craniofacial skeletal tissue homeostasis, injury, repair the presence hormone therapy Epidemiologic research the prevalence unmet dental, oral, and/or craniofacial needs SGM individuals, e.g., oral cancers, oral complications HIV/AIDS, orofacial trauma Research identifying explanatory mechanisms oral health disparities SGM individuals populations Research reduce oral health disparities SGM individuals populations, targeting individual, family, community, provider, health system, and/or policy levers change NIDDKsupports medical research research training dissemination science-based information diabetes other endocrine metabolic diseases; digestive diseases, nutritional disorders, obesity; kidney, urologic, hematologic diseases, improve peoples health quality life. Areas programmatic interest toNIEHSinclude are limited to: Studies better understand impact environmental exposures, such endocrine disrupting chemicals, gonadal development other hormonal systems affect sexual development Development resources, approaches, technologies will promote research environmental conditions effect health sexual gender minority populations Areas programmatic interest toNIMHinclude: Identification mutable mechanistic causes disparities mental health-related clinical including suicide thoughts behaviors) functional outcomes including Severe Mental Illness) which interventions targeting health equity be developed tested. could include interventions the individual, family, provider, clinic system-level, based the empirical evidence the contributing factor(s). Descriptive studies the prevalence characteristics mental disorders SGM individuals considered low priority. more details NIMH support intervention studies, please see:https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml. Studies how non-mental health specialty settings e.g., SGM social support groups, human resources employee assistance programs, educational settings, etc.) contribute and support screening, referral, diagnosis treatment prevention mental illness suicide behavior SGM populations. development testing stigma reduction interventions and/or interventions address social cultural barriers not only change knowledge/attitudes/beliefs also lead behavior change consumers providers) structural change the clinic system level) improves access, engagement, retention, treatment adherence, quality care mental health outcomes including suicide risk) SGM across life course. Studies proposing adapt/augment interventions SGM racial ethnic minority groups should provide empirical basis the need intervention tailoring how is expected achieve equity mental health-related outcomes among those groups. Studies better understand disparities HIV rates outcomes among SGM living HIV how mitigate as well a better understanding the factors impeding scale of efficacious HIV prevention interventions SGM the development approaches address barriers. NIMHalso seeks studies that: Include sufficient numbers SGM individuals enable robust sub-group analyses. Conduct secondary data analyses identify strategies improving quality mental health care SGM individuals. Areas programmatic interest toNINDSinclude are limited to: Research health disparities SGM populations relevant neurological disorders fall within scientific mission the NINDS https://www.ninds.nih.gov/About-NINDS/Who-We-Are/Mission). Research the effects exogenous hormone among transgender and/or intersex individuals neurological function neurological disorders. Research risk factors neurological disorders SGM populations. Inquiries Please direct inquiries to: Jennifer Alvidrez, PhD National Institute Minority Health Health Disparities NIMHD) Telephone: 301-594-9567 Email:jennifer.alvidrez@nih.gov Della B. White, PhD National Center Complementary & Integrative Health NCCIH) Telephone: 301-827-6358 Email:Della.White@nih.gov Elizabeth Perruccio, PhD National Cancer Institute NCI) Telephone: 240-276-6178 Email:liz.perruccio@nih.gov Christine Gatlin, Ph.D. National Human Genome Research Institute NHGRI) Telephone: 301-480-2280 Email:gatlincl@mail.nih.gov Brad Newsome, PhD National Heart, Lung, Blood Institute NHLBI) Telephone: 301-827-8170 Email:brad.newsome@nih.gov Melissa S. Gerald, PhD National Institute Aging NIA) Telephone: 301-496-3136 Email:melissa.gerald@nih.gov Robert C. Freeman, PhD National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-8820 Email:rfreeman@mail.nih.gov Philip Renzullo, PhD, MPH National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3041 Email:prenzullo@niaid.nih.gov Heiyoung Park, PhD National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-594-3507 Email:Heiyoung.Park@nih.gov Regina Bures, PhD Eunice Kennedy ShriverNational Institute Child Health Human Development NICHD) Telephone: 301-496-9485 Email:regina.bures@nih.gov Jeffrey Schulden, MD National Institute Drug Abuse NIDA) Telephone: 301-402-1526 Email:schuldenj@nida.nih.gov Dena Fischer, DDS, MSD, MS National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-4876 Email:dena.fischer@nih.gov Tamara Bavendam, MD, MS National Institute Diabetes Digestive Kidney Diseases NIDDK) Telephone: 301-594-4733 Email:bavendamtg@mail.nih.gov Thaddeus Schug, PhD National Institute Environmental Health Sciences NIEHS) Telephone: 984-287-3319 Email:schugt2@niehs.nih.gov Tamara Lewis-Johnson, MBA, MPH National Institute Mental Health NIMH) Telephone: 301-594-7963 Email:tamara.lewisjohnson@nih.gov Richard T. Benson, MD, PhD National Institute Neurological Disorders Stroke NINDS) Phone: 301-496-9135 E-mail: Richard.benson@nih.gov Kate Winseck, MSW Office Disease Prevention ODP) Telephone: 301-827-5583 Email:winseckk@mail.nih.gov Victoria Cargill, MD, MSCE, AAHIVS Office Research Womens Health ORWH) Telephone: 301-435-0971 Email:cargillv@od.nih.gov Karen L. Parker, PhD, MSW Sexual & Gender Minority Research Office SGMRO) Telephone: 301-451-2055 Email:Klparker@mail.nih.gov

Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)

PAR
Friday, November 16, 2018
Clinical Trials Research
Saturday, November 13, 2021
R01
PAR-19-070

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing research on current topics in Alzheimer's disease and its related dementias. Further information on the high-priority topics of interest will be announced through a series of Notices published subsequent to this FOA.

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

PA
Wednesday, June 20, 2018
Workforce Diversity
Sunday, September 5, 2021
333
PA-18-837

Funding Opportunity Purpose

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Small Business Concerns (SBCs) holding Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be nationally underrepresented in health-related research or in the SBIR program. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Pages